Aurobindo Pharma receives USFDA tentative approval for Sildenafil Citrate Tablets

21 Jul 2015 Evaluate

Aurobindo Pharma has received tentative approval from the US Food & Drug Administration (USFDA) to manufacture and market Sildenafil Citrate Tablets 25 mg, 50 mg and 100 mg. Viagra is the brand name for Sildenafil Citrate, and is used for treating erectile dysfunction and pulmonary arterial hypertension.

Aurobindo is a 'Vertically Integrated' pharmaceutical companies in India, It has robust product portfolio spread over major product areas encompassing CVS, CNS, Anti-Retroviral, Antibiotics, Gastroenterologicals, Anti-Diabetics and Anti-Allergic with approved manufacturing facilities by USFDA, UKMHRA, WHO, MCC-SA, ANVISA-Brazil for both APIs & Formulations.


Aurobindo Pharma Share Price

1140.15 10.00 (0.88%)
28-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.15
Dr. Reddys Lab 1224.30
Cipla 1328.25
Zydus Lifesciences 896.60
Lupin 2121.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×